Publication | Open Access
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study
25
Citations
37
References
2017
Year
Our analysis, reflective of real clinical practice, shows for the first time the high economic cost of mCRPC in Italy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1